Comment on: Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome: reply

Virginie Dufrost¹, Jessie Risse^{1

2}, Denis Wahl^{1

2}, Stéphane Zuily^{1

2}

Affiliations

¹ Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, France.
² Inserm UMR_S 1116 at Lorraine University, Nancy, France.

Comment

Virginie Dufrost et al. Rheumatology (Oxford). 2018.

. 2018 May 1;57(5):939-940.

doi: 10.1093/rheumatology/kex464.

Virginie Dufrost¹, Jessie Risse^{1

2}, Denis Wahl^{1

2}, Stéphane Zuily^{1

2}

¹ Vascular Medicine Division and Regional Competence Center for Rare Vascular and Systemic Autoimmune Diseases, CHRU de Nancy, France.
² Inserm UMR_S 1116 at Lorraine University, Nancy, France.

No abstract available

Comment on

Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome.
Dufrost V, Risse J, Kirchner S, Zuily S, Wahl D. Dufrost V, et al. Rheumatology (Oxford). 2017 Aug 1;56(8):1433-1434. doi: 10.1093/rheumatology/kex086. Rheumatology (Oxford). 2017. PMID: 28431092 No abstract available.
Comment on: Failure of rivaroxaban to prevent thrombosis in four patients with anti-phospholipid syndrome.
Scanvion Q, Morell-Dubois S, Yelnik CM, Bene J, Gautier S, Lambert M. Scanvion Q, et al. Rheumatology (Oxford). 2018 May 1;57(5):938-939. doi: 10.1093/rheumatology/kex463. Rheumatology (Oxford). 2018. PMID: 29373704 No abstract available.